Ganglion Medical Center

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02	NCT07449923
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)	eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 3	2026-09-17	NCT06373731
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03	NCT06683742
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration	eye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degeneration	Recruiting	Phase 3	2026-04-16	NCT07064759

Clinical trials